1![NOT FOR IMMEDIATE RELEASE SHIONOGI & CO., LTD ANNOUNCES THAT NALDEMEDINE MEETS PRIMARY ENDPOINT IN A PHASE 3 STUDY FOR THE TREATMENT OF OPIOID-INDUCED CONSTIPATION FLORHAM PARK, NJ (March 30, 2015) – Naldemedine, an i NOT FOR IMMEDIATE RELEASE SHIONOGI & CO., LTD ANNOUNCES THAT NALDEMEDINE MEETS PRIMARY ENDPOINT IN A PHASE 3 STUDY FOR THE TREATMENT OF OPIOID-INDUCED CONSTIPATION FLORHAM PARK, NJ (March 30, 2015) – Naldemedine, an i](https://www.pdfsearch.io/img/93bb0edfe66ac4bbe402b8679bf7906f.jpg) | Add to Reading ListSource URL: shionogi616.tew-staging.comLanguage: English - Date: 2015-04-27 07:57:32
|
---|
2![Needham & Company 2015 Healthcare Conference Stephen Doberstein, Ph.D. Senior Vice President & Chief Scientific Officer April 15, 2015 Needham & Company 2015 Healthcare Conference Stephen Doberstein, Ph.D. Senior Vice President & Chief Scientific Officer April 15, 2015](https://www.pdfsearch.io/img/b11b21d47388405413cd1c79e04bfe32.jpg) | Add to Reading ListSource URL: www.nektar.comLanguage: English - Date: 2015-04-15 08:48:13
|
---|
3![Managing_Opioid-Induced_Constipation Managing_Opioid-Induced_Constipation](https://www.pdfsearch.io/img/1460d34c8ed9c674da3e790da6087f96.jpg) | Add to Reading ListSource URL: www.2ndchance.infoLanguage: English - Date: 2014-02-04 18:20:56
|
---|
4![Methylnaltrexone (Relistor®) A novel treatment for opioid-induced constipation http://www.healthandherbs.co.nz/Health-Library/Digestion--Gastrointestinal-Health/Resveratrol-for-Digestive-Health/default.aspx Heather A. Methylnaltrexone (Relistor®) A novel treatment for opioid-induced constipation http://www.healthandherbs.co.nz/Health-Library/Digestion--Gastrointestinal-Health/Resveratrol-for-Digestive-Health/default.aspx Heather A.](https://www.pdfsearch.io/img/d796792b355b1f004bc2e79b23926f30.jpg) | Add to Reading ListSource URL: www.utexas.eduLanguage: English - Date: 2010-12-16 08:31:43
|
---|
5![TXT_PI_US_Relistor_20mg/mL Injectable_4.0 TXT_PI_US_Relistor_20mg/mL Injectable_4.0](https://www.pdfsearch.io/img/5f7a602aae59267a89cb33456db41c98.jpg) | Add to Reading ListSource URL: cdn.salix.comLanguage: English - Date: 2014-10-06 12:28:23
|
---|
6![Giazo Patient Information Form_0412 Giazo Patient Information Form_0412](https://www.pdfsearch.io/img/6375bd94e82c6b9c036e43b5a6c81a64.jpg) | Add to Reading ListSource URL: cdn.salix.comLanguage: English - Date: 2014-11-10 12:16:17
|
---|
7![Cardiovascular Assessment of Peripherally Active Mu-Opioid Antagonists Donna Griebel, M.D. Division of Gastroenterology and Inborn Errors Products June 11, 2014 Cardiovascular Assessment of Peripherally Active Mu-Opioid Antagonists Donna Griebel, M.D. Division of Gastroenterology and Inborn Errors Products June 11, 2014](https://www.pdfsearch.io/img/9b81767a5d05c08f7f194dbfc2407552.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
8![Kentucky Department for Medicaid Services Kentucky Department for Medicaid Services](https://www.pdfsearch.io/img/996f7b7783ce3b11f9f28f1fbf639474.jpg) | Add to Reading ListSource URL: chfs.ky.govLanguage: English - Date: 2014-11-28 00:41:41
|
---|
9![C-1 Alvimopan— Retrospective Evaluation of Opioid Withdrawal and Cardiovascular Safety With Long-term Use in Opioid-Induced Constipation C-1 Alvimopan— Retrospective Evaluation of Opioid Withdrawal and Cardiovascular Safety With Long-term Use in Opioid-Induced Constipation](https://www.pdfsearch.io/img/d46a0814c1e0ff388b77bf2992a0b949.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
10![Microsoft PowerPoint - AADPAC_Salix Presentation_Show FIle.pptx Microsoft PowerPoint - AADPAC_Salix Presentation_Show FIle.pptx](https://www.pdfsearch.io/img/6cec99b51b0f541bd7890d05858c349c.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|